| LUMRYZ FLAMEL IRELAND LIMITED
2145041 14 Sep 2021 | on 09 Aug 2023 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparation acting on the central nervous system for treating somnipathy, chronic and acute fatigue, and sleep-wake cycle disorders; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases, namely, somnipathy, chronic and acute fatigue, and sleep-wake cycle disorders | | | LUMRYZ FLAMEL IRELAND LIMITED
2028141 20 Mar 2020 | on 23 Nov 2022 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparation acting on the central nervous system for treating somnipathy, chronic and acute fatigue, and sleep-wake cycle disorders; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, insomnia and other sleep related diseases; Medication for central nervous system disorders and diseases and sleep disorders and diseases, namely, somnipathy, chronic and acute fatigue, and sleep-wake cycle disorders. | | | Lumryz 7.5 g per packet Flamel Ireland Limited
2211552 17 Aug 2022 | on 15 Nov 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparation acting on the central nervous system for treating somnipathy, chronic and acute fatigue, and sleep-wake cycle disorders; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases. | | | Lumryz 4.5 g per packet Flamel Ireland Limited
2198024 13 Jun 2022 | on 15 Nov 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparation acting on the central nervous system for treating somnipathy, chronic and acute fatigue, and sleep-wake cycle disorders; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases. | | | Lumryz 6 g per packet Flamel Ireland Limited
2198025 13 Jun 2022 | on 15 Nov 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparation acting on the central nervous system for treating somnipathy, chronic and acute fatigue, and sleep-wake cycle disorders; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases. | | | Lumryz 9 g per packet Flamel Ireland Limited
2198026 13 Jun 2022 | on 15 Nov 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparation acting on the central nervous system for treating somnipathy, chronic and acute fatigue, and sleep-wake cycle disorders; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases. | | 
